Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H33N2O |
Molecular Weight | 353.5209 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C
InChI
InChIKey=JTPUMZTWMWIVPA-UHFFFAOYSA-O
InChI=1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1
Isopropamide is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13259723
Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/isopropamide-iodide.html
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01005 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | DARBID Approved UseIsopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold. Launch Date1957 |
|||
Primary | DARBID Approved UseIsopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold. Launch Date1957 |
PubMed
Title | Date | PubMed |
---|---|---|
Spectrophotometric determination of trifluoperazine HCl and isopropamide iodide in binary mixture using second derivative and second derivative of the ratio spectra methods. | 2001 Sep |
|
Derivative spectrophotometric, thin layer chromatographic-densitometric and high performance liquid chromatographic determination of trifluoperazine hydrochloride in presence of its hydrogen peroxide induced-degradation product. | 2002 Jan 1 |
|
Evaluation of antimotility effect of Lantana camara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in mice. | 2005 Sep 17 |
|
Annotation of novel neuropeptide precursors in the migratory locust based on transcript screening of a public EST database and mass spectrometry. | 2006 Aug 9 |
|
Simultaneous RP-HPLC Estimation of Trifluoperazine Hydrochloride and Chlordiazepoxide in Tablet Dosage Forms. | 2009 Sep |
|
Spectrophotometric determination of isopropamide iodide and trifluoperazine hydrochloride in presence of trifluoperazine oxidative degradate. | 2010 Apr |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
|
2-Hydroxy-N,N'-diisopropylpropane-1,3-diaminium dichloride. | 2010 Jun 23 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29133
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.1921
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
CFR |
21 CFR 520.1920
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
WHO-ATC |
A03CA01
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
WHO-VATC |
QA03AB09
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
CFR |
21 CFR 522.1920
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
WHO-ATC |
A03AB09
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
WHO-VATC |
QA03CA01
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
||
|
NCI_THESAURUS |
C66880
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ISOPROPAMIDE
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
DTXSID9023174
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
C73139
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
89784
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
3775
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
8B9I31H724
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
7492-32-2
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
DB01625
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
100000086458
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
1500
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
231-316-9
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY | |||
|
SUB02799MIG
Created by
admin on Fri Dec 15 16:14:43 GMT 2023 , Edited by admin on Fri Dec 15 16:14:43 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)